{
  "main_header": {
    "sid": 1150075,
    "name": "Veradigm, Inc.",
    "stock_name": "Veradigm, Inc.",
    "full_name": "Veradigm, Inc.",
    "name_url": "stocks-analysis/veradigm-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "4.85",
    "chg": 0.1,
    "chgp": "2.11%",
    "dir": 1,
    "prev_price": "4.75",
    "mcapval": "1,569.97",
    "mcap": "",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Software Products",
    "ind_code": 3310,
    "indexname": "S&P 500",
    "isin": "US01988P1084",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "39.01 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/veradigm-inc-1150075-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Veradigm, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-veradigm-inc-technically-bullish-or-bearish-3547246",
        "imagepath": "",
        "date": "2025-09-20 19:50:39",
        "description": "As of 5 September 2025, the technical trend for Veradigm, Inc. has changed from sideways to mildly bearish. The current stance is bearish, with key indicators driving this sentiment including a bearish daily moving average and a bearish monthly MACD. Although the weekly MACD and KST are mildly bullish, they are overshadowed by the overall bearish signals in the monthly timeframe. Additionally, the stock has significantly underperformed against the S&P 500, with a year-to-date return of -52.31% compared to the S&P's 12.22%...."
      },
      {
        "title": "Is Veradigm, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-veradigm-inc-overvalued-or-undervalued-3543656",
        "imagepath": "",
        "date": "2025-09-20 18:25:05",
        "description": "As of 8 July 2024, the valuation grade for Veradigm, Inc. has moved from expensive to does not qualify, indicating a significant deterioration in its valuation outlook. The company appears to be overvalued given its high P/E ratio of 142, an EV to EBIT of 56.85, and a Price to Book Value of 1.40, which are all considerably elevated compared to its peers. For instance, NextGen Healthcare, Inc. has a fair valuation with a P/E ratio of -1604.29 and an EV to EBITDA of 35.23, suggesting that Veradigm's metrics are not justified in the current market context.\n\nThe stock has significantly underperformed against the S&P 500, with a year-to-date return of -52.31% compared to the S&P 500's 12.22%, and a three-year return of -71.45% versus the S&P 500's 70.41%. This stark contrast reinforces the notion that Veradigm is overvalued in its current state...."
      }
    ],
    "total": 7,
    "sid": "1150075",
    "stock_news_url": "https://www.marketsmojo.com/news/veradigm-inc-1150075"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is Veradigm, Inc. technically bullish or bearish?

2025-09-20 19:50:39

As of 5 September 2025, the technical trend for Veradigm, Inc. has changed from sideways to mildly bearish. The current stance is bearish, with key indicators driving this sentiment including a bearish daily moving average and a bearish monthly MACD. Although the weekly MACD and KST are mildly bullish, they are overshadowed by the overall bearish signals in the monthly timeframe. Additionally, the stock has significantly underperformed against the S&P 500, with a year-to-date return of -52.31% compared to the S&P's 12.22%....

Read More

Is Veradigm, Inc. overvalued or undervalued?

2025-09-20 18:25:05

As of 8 July 2024, the valuation grade for Veradigm, Inc. has moved from expensive to does not qualify, indicating a significant deterioration in its valuation outlook. The company appears to be overvalued given its high P/E ratio of 142, an EV to EBIT of 56.85, and a Price to Book Value of 1.40, which are all considerably elevated compared to its peers. For instance, NextGen Healthcare, Inc. has a fair valuation with a P/E ratio of -1604.29 and an EV to EBITDA of 35.23, suggesting that Veradigm's metrics are not justified in the current market context. The stock has significantly underperformed against the S&P 500, with a year-to-date return of -52.31% compared to the S&P 500's 12.22%, and a three-year return of -71.45% versus the S&P 500's 70.41%. This stark contrast reinforces the notion that Veradigm is overvalued in its current state....

Read More

View All News